ENANTA PHARMACEUTICALS, INC — Net Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e26b50b4-245a-4a69-9824-03c0b706ec9a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-81.9M | 2024-10-01 – 2025-09-30 | evidence 0001193125-25-288121 |
| FY 2024 | $-116.0M | 2023-10-01 – 2024-09-30 | evidence 0000950170-24-131260 |
| FY 2023 | $-133.8M | 2022-10-01 – 2023-09-30 | evidence 0000950170-23-065884 |
| FY 2022 | $-121.8M | 2021-09-30 – 2022-09-30 | evidence 0000950170-23-002134 |
| FY 2021 | $-79.0M | 2020-10-01 – 2021-09-30 | evidence 0000950170-21-004895 |
| FY 2020 | $-36.2M | 2019-10-01 – 2020-09-30 | evidence 0001564590-20-055233 |
| FY 2019 | $46.4M | 2018-10-01 – 2019-09-30 | evidence 0001564590-19-044729 |
| FY 2018 | $72.0M | 2017-10-01 – 2018-09-30 | evidence 0001564590-18-030275 |
| FY 2017 | $17.7M | 2016-10-01 – 2017-09-30 | evidence 0001564590-17-024794 |
| FY 2016 | $21.7M | 2015-10-01 – 2016-09-30 | evidence 0001193125-16-789660 |
| FY 2015 | $79.0M | 2014-10-01 – 2015-09-30 | evidence 0001193125-15-401602 |
| FY 2014 | $34.4M | 2013-10-01 – 2014-09-30 | evidence 0001193125-14-440235 |
| FY 2013 | $9.6M | 2012-10-01 – 2013-09-30 | evidence 0001193125-13-477878 |
| FY 2012 | $21.4M | 2011-10-01 – 2012-09-30 | evidence 0001193125-13-477878 |
| FY 2011 | $23.3M | 2010-10-01 – 2011-09-30 | evidence 0001193125-13-477878 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ENANTA PHARMACEUTICALS, INC — all facts · Revenue · Operating Income